Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
PLoS Genet ; 15(1): e1007896, 2019 01.
Article in English | MEDLINE | ID: mdl-30677018

ABSTRACT

Neurons typically release both a small-molecule neurotransmitter and one or more neuropeptides, but how these two types of signal from the same neuron might act together remains largely obscure. For example, serotonergic neurons in mammalian brain express the neuropeptide Substance P, but it is unclear how this co-released neuropeptide might modulate serotonin signaling. We studied this issue in C. elegans, in which all serotonergic neurons express the neuropeptide NLP-3. The serotonergic Hermaphrodite Specific Neurons (HSNs) are command motor neurons within the egg-laying circuit which have been shown to release serotonin to initiate egg-laying behavior. We found that egg-laying defects in animals lacking serotonin were far milder than in animals lacking HSNs, suggesting that HSNs must release other signal(s) in addition to serotonin to stimulate egg laying. While null mutants for nlp-3 had only mild egg-laying defects, animals lacking both serotonin and NLP-3 had severe defects, similar to those of animals lacking HSNs. Optogenetic activation of HSNs induced egg laying in wild-type animals, and in mutant animals lacking either serotonin or NLP-3, but failed to induce egg laying in animals lacking both. We recorded calcium activity in the egg-laying muscles of animals lacking either serotonin, NLP-3, or both. The single mutants, and to a greater extent the double mutant, showed muscle activity that was uncoordinated and unable to expel eggs. Specifically, the vm2 muscles cells, which are direct postsynaptic targets of the HSN, failed to contract simultaneously with other egg-laying muscle cells. Our results show that the HSN neurons use serotonin and the neuropeptide NLP-3 as partially redundant co-transmitters that together stimulate and coordinate activity of the target cells onto which they are released.


Subject(s)
Behavior, Animal , Neuropeptides/genetics , Oviposition/genetics , Serotonin/genetics , Acetylcholine/genetics , Acetylcholine/metabolism , Animals , Caenorhabditis elegans/genetics , Caenorhabditis elegans/physiology , Disorders of Sex Development/genetics , Female , Male , Motor Neurons/metabolism , Mutation , Neurotransmitter Agents/genetics , Serotonergic Neurons/metabolism , Signal Transduction
2.
Elife ; 52016 11 16.
Article in English | MEDLINE | ID: mdl-27849154

ABSTRACT

Like many behaviors, Caenorhabditis elegans egg laying alternates between inactive and active states. To understand how the underlying neural circuit turns the behavior on and off, we optically recorded circuit activity in behaving animals while manipulating circuit function using mutations, optogenetics, and drugs. In the active state, the circuit shows rhythmic activity phased with the body bends of locomotion. The serotonergic HSN command neurons initiate the active state, but accumulation of unlaid eggs also promotes the active state independent of the HSNs. The cholinergic VC motor neurons slow locomotion during egg-laying muscle contraction and egg release. The uv1 neuroendocrine cells mechanically sense passage of eggs through the vulva and release tyramine to inhibit egg laying, in part via the LGC-55 tyramine-gated Cl- channel on the HSNs. Our results identify discrete signals that entrain or detach the circuit from the locomotion central pattern generator to produce active and inactive states.


Subject(s)
Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans/genetics , Chloride Channels/genetics , Feedback, Physiological , Oviposition/genetics , Receptors, Biogenic Amine/genetics , Sexual Behavior, Animal/physiology , Animals , Caenorhabditis elegans/drug effects , Caenorhabditis elegans/growth & development , Caenorhabditis elegans/metabolism , Caenorhabditis elegans Proteins/metabolism , Chloride Channels/metabolism , Choline/metabolism , Choline/pharmacology , Female , Gene Expression Regulation , Locomotion , Motor Neurons/cytology , Motor Neurons/drug effects , Motor Neurons/metabolism , Muscle Contraction/drug effects , Muscle Contraction/genetics , Optogenetics , Oviposition/drug effects , Periodicity , Receptors, Biogenic Amine/metabolism , Serotonin/metabolism , Serotonin/pharmacology , Sexual Behavior, Animal/drug effects , Signal Transduction , Tyramine/metabolism , Tyramine/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL
...